BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4472653)

  • 1. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.
    McPartland RP; Wang MC; Bloch A; Weinfeld H
    Cancer Res; 1974 Nov; 34(11):3107-11. PubMed ID: 4472653
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
    Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
    Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
    Karle JM; Cysyk RL
    Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
    Moyer JD; Malinowski NM; Treanor SP; Marquez VE
    Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labelling of the thymidine and deoxycytidine bases of DNA by [2-14C]deoxycytidine in cultured L1210 cells.
    Karle JM; Hoerauf RM; Cysyk RL
    Cancer Lett; 1983 Jun; 19(2):147-57. PubMed ID: 6883305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
    Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
    J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of two cyclopentenyl-3-deazapyrimidine carbocyclic nucleosides related to cytidine and uridine.
    Copp RR; Marquez VE
    J Med Chem; 1991 Jan; 34(1):208-12. PubMed ID: 1992119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
    Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
    Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 3-deazauridine and dipyridamole on uridine utilization by mice.
    Moyer JD; Malinowski N; Cysyk RL
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):323-7. PubMed ID: 2423341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of cytidine triphosphate synthetase in Salmonella typhimurium by pyrimidines during uridine nucleotide depletion.
    West TP; O'Donovan GA
    J Gen Microbiol; 1982 Apr; 128(4):895-9. PubMed ID: 6750041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
    Moriconi WJ; Slavik M; Taylor S
    Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to 5-fluorouracil associated with increased cytidine triphosphate levels in V79 Chinese hamster cells.
    Kaufman ER
    Cancer Res; 1984 Aug; 44(8):3371-6. PubMed ID: 6744271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD; Grindey GB; Kline I; Waravdekar VS
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract]   [Full Text] [Related]  

  • 19. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland?
    Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R
    Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of uridine-cytidine kinase derived from L1210 leukemia cells.
    Ahmed NK; Baker DR
    Cancer Res; 1980 Oct; 40(10):3559-63. PubMed ID: 6254634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.